Announced
Completed
Synopsis
Cosette Pharmaceuticals completed the acquisition of eight branded commercial products from Daiichi Sankyo, a Japanese pharmaceutical company. Financial terms were not disclosed. “This transformative acquisition represents a significant expansion and diversification of Cosette’s portfolio and business. We look forward to building on this transaction and successfully acquire and integrate important product portfolios in the future, and to continue to make these critical medications available for patients and prescribers,” Apurva Saraf, Cosette President and CEO.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.